Procoagulant Extracellular Vesicles Alter Trophoblast Differentiation in Mice by a Thrombo-Inflammatory Mechanism.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Sep 2021
Historique:
received: 17 08 2021
revised: 02 09 2021
accepted: 07 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 21 10 2021
Statut: epublish

Résumé

Procoagulant extracellular vesicles (EV) and platelet activation have been associated with gestational vascular complications. EV-induced platelet-mediated placental inflammasome activation has been shown to cause preeclampsia-like symptoms in mice. However, the effect of EV-mediated placental thrombo-inflammation on trophoblast differentiation remains unknown. Here, we identify that the EV-induced thrombo-inflammatory pathway modulates trophoblast morphology and differentiation. EVs and platelets reduce syncytiotrophoblast differentiation while increasing giant trophoblast and spongiotrophoblast including the glycogen-rich cells. These effects are platelet-dependent and mediated by the NLRP3 inflammasome. In humans, inflammasome activation was negatively correlated with trophoblast differentiation marker GCM1 and positively correlated with blood pressure. These data identify a crucial role of EV-induced placental thrombo-inflammation on altering trophoblast differentiation and suggest platelet activation or inflammasome activation as a therapeutic target in order to achieve successful placentation.

Identifiants

pubmed: 34576036
pii: ijms22189873
doi: 10.3390/ijms22189873
pmc: PMC8466022
pii:
doi:

Substances chimiques

DNA-Binding Proteins 0
Gcm1 protein, mouse 0
Inflammasomes 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : KO 5736/1-1
Organisme : Deutsche Forschungsgemeinschaft
ID : IS-67/4-3
Organisme : Deutsche Forschungsgemeinschaft
ID : IS 67/16-

Références

Blood. 2016 Oct 27;128(17):2153-2164
pubmed: 27589872
Immunity. 2019 Jul 16;51(1):50-63.e5
pubmed: 31174991
BMC Pregnancy Childbirth. 2014 Jul 22;14:241
pubmed: 25048443
J Mol Med (Berl). 2020 Feb;98(2):193-207
pubmed: 31863152
Kidney Int. 2015 Jan;87(1):74-84
pubmed: 25075770
Nat Rev Genet. 2020 Jan;21(1):27-43
pubmed: 31534202
Science. 1998 Dec 11;282(5396):2072-5
pubmed: 9851926
J Biol Chem. 2012 Feb 17;287(8):5400-11
pubmed: 22174410
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2594-604
pubmed: 16990554
Front Endocrinol (Lausanne). 2018 Sep 27;9:570
pubmed: 30319550
Cell Death Differ. 2009 May;16(5):719-27
pubmed: 19219068
Curr Pharm Biotechnol. 2018;19(10):764-770
pubmed: 30378495
Semin Thromb Hemost. 1997;23(4):349-56
pubmed: 9263351
Hypertension. 2017 Aug;70(2):372-381
pubmed: 28607124
Endocrinology. 2016 Feb;157(2):883-99
pubmed: 26653761
Mol Cell Endocrinol. 2002 Feb 22;187(1-2):207-12
pubmed: 11988329
Endocrinology. 2008 Mar;149(3):1243-51
pubmed: 18079197
Hypertension. 2012 Mar;59(3):732-9
pubmed: 22275534
Placenta. 2017 Jun;54:52-58
pubmed: 28117144
Front Immunol. 2019 Sep 13;10:2204
pubmed: 31572400
Placenta. 2005 Apr;26 Suppl A:S3-9
pubmed: 15837063
J Thromb Haemost. 2016 Nov;14(11):2212-2226
pubmed: 27590316
N Engl J Med. 2017 Aug 17;377(7):613-622
pubmed: 28657417
Blood. 2021 Feb 18;137(7):977-982
pubmed: 32870264
Pediatr Res. 2001 Aug;50(2):203-9
pubmed: 11477204
Nat Rev Genet. 2001 Jul;2(7):538-48
pubmed: 11433360
Cell Death Dis. 2017 Apr 6;8(4):e2730
pubmed: 28383551
Blood. 2005 Jul 15;106(2):428-35
pubmed: 15797992
Pregnancy Hypertens. 2011 Jan;1(1):79-86
pubmed: 26104234
Clin Immunol. 2018 Dec;197:154-160
pubmed: 30236770
J Immunol. 2019 Dec 1;203(11):2757-2769
pubmed: 31740550
J Extracell Vesicles. 2018 Mar 26;7(1):1454777
pubmed: 29696077

Auteurs

Paulina Markmeyer (P)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig University, 04103 Leipzig, Germany.
Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany.

Franziska Lochmann (F)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig University, 04103 Leipzig, Germany.
Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany.

Kunal Kumar Singh (KK)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig University, 04103 Leipzig, Germany.

Anubhuti Gupta (A)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig University, 04103 Leipzig, Germany.

Ruaa Younis (R)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig University, 04103 Leipzig, Germany.

Khurrum Shahzad (K)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig University, 04103 Leipzig, Germany.

Ronald Biemann (R)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig University, 04103 Leipzig, Germany.

Hanna Huebner (H)

Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, 91054 Erlangen, Germany.

Matthias Ruebner (M)

Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, 91054 Erlangen, Germany.

Berend Isermann (B)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig University, 04103 Leipzig, Germany.

Shrey Kohli (S)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig University, 04103 Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH